Page last updated: 2024-08-24

ibandronic acid and Fibrocartilaginous Dysplasia of Bone

ibandronic acid has been researched along with Fibrocartilaginous Dysplasia of Bone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Economidou, D; Ginikopoulou, E; Memmos, D; Minasidis, E; Mitsopoulos, E; Pateinakis, P; Thodis, E; Tsakiris, D; Vargemezis, V; Zanos, S1

Other Studies

1 other study(ies) available for ibandronic acid and Fibrocartilaginous Dysplasia of Bone

ArticleYear
Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study.
    American journal of nephrology, 2012, Volume: 36, Issue:3

    Topics: Aged; Biopsy; Bone Density; Bone Density Conservation Agents; Cinacalcet; Diphosphonates; Female; Femur Neck; Fibrous Dysplasia of Bone; Humans; Ibandronic Acid; Lumbar Vertebrae; Male; Middle Aged; Naphthalenes; Pilot Projects; Renal Dialysis; Risk; Teriparatide; Treatment Outcome

2012